Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma

Clinical trial NCT00010049 · COMPLETED

Trial details

NCT number: NCT00010049
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2001-02-27
Primary completion: 2005-03-17
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.